Pr Zhang - Ranplan Chief CoFounder
| RPLAN Stock | SEK 1.45 0.00 0.00% |
Insider
Pr Zhang is Chief CoFounder of Ranplan Group
| Age | 56 |
| Web | https://www.ranplanwireless.com |
Ranplan Management Efficiency
The company has return on total asset (ROA) of (0.667) % which means that it has lost $0.667 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (18.126) %, meaning that it generated substantial loss on money invested by shareholders. Ranplan's management efficiency ratios could be used to measure how well Ranplan manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Inbal MazorBadichi | Surgical Science Sweden | 54 | |
| Adv | Surgical Science Sweden | 55 | |
| Doron Zilberman | Surgical Science Sweden | 61 | |
| Filip Arenbo | Lime Technologies AB | 36 | |
| Anna Ahlberg | Surgical Science Sweden | 53 | |
| Daniel Zhang | Teqnion AB | 34 | |
| Nils Olsson | Lime Technologies AB | 40 | |
| Anders Larsson | Surgical Science Sweden | 50 | |
| AnnaKarin Karlsson | Teqnion AB | 50 | |
| Magnus Hansson | Lime Technologies AB | 50 | |
| Jeffrey Berkley | Surgical Science Sweden | 54 | |
| Ran Bronstein | Surgical Science Sweden | 59 | |
| Gustav Kinnander | FormPipe Software AB | N/A | |
| Anna Hansen | Lime Technologies AB | 45 | |
| Tommas Davoust | Lime Technologies AB | 40 | |
| Gisli Hennermark | Surgical Science Sweden | 51 | |
| Martin Jansson | Surgical Science Sweden | 52 | |
| Daniel Evestedt | Surgical Science Sweden | 46 | |
| Pernilla Moller | Lime Technologies AB | 44 | |
| Vishal Ganatra | Lime Technologies AB | 41 | |
| Mona Axman | Teqnion AB | 50 | |
Management Performance
| Return On Equity | -18.13 | |||
| Return On Asset | -0.67 |
Ranplan Group Leadership Team
Elected by the shareholders, the Ranplan's board of directors comprises two types of representatives: Ranplan inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Ranplan. The board's role is to monitor Ranplan's management team and ensure that shareholders' interests are well served. Ranplan's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Ranplan's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Yuhua Wu, COO Founder | ||
| Per Lindberg, Independent Director | ||
| George Wells, Chief Officer | ||
| Jon Ullmark, Global Officer | ||
| Jason Suplita, Head Marketing | ||
| Pr Zhang, Chief CoFounder | ||
| Anthony Sutton, Chief Officer | ||
| Hui Song, Chief Technical Officer |
Ranplan Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Ranplan a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -18.13 | |||
| Return On Asset | -0.67 | |||
| Profit Margin | (1.36) % | |||
| Operating Margin | (1.24) % | |||
| Current Valuation | 49.01 M | |||
| Shares Outstanding | 30.44 M | |||
| Shares Owned By Insiders | 80.04 % | |||
| Shares Owned By Institutions | 5.25 % | |||
| Price To Book | 3.84 X | |||
| Price To Sales | 2.92 X |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Ranplan Stock Analysis
When running Ranplan's price analysis, check to measure Ranplan's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ranplan is operating at the current time. Most of Ranplan's value examination focuses on studying past and present price action to predict the probability of Ranplan's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ranplan's price. Additionally, you may evaluate how the addition of Ranplan to your portfolios can decrease your overall portfolio volatility.